Alkem Laboratories Limited (NSE:ALKEM)
5,069.00
-225.50 (-4.26%)
May 30, 2025, 10:30 AM IST
Alkem Laboratories Revenue
Alkem Laboratories had revenue of 33.74B INR in the quarter ending December 31, 2024, with 1.52% growth. This brings the company's revenue in the last twelve months to 127.57B, up 0.97% year-over-year. In the fiscal year ending March 31, 2024, Alkem Laboratories had annual revenue of 126.68B with 9.21% growth.
Revenue (ttm)
127.57B
Revenue Growth
+0.97%
P/S Ratio
4.70
Revenue / Employee
7.72M
Employees
17,432
Market Cap
633.04B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 126.68B | 10.68B | 9.21% |
Mar 31, 2023 | 115.99B | 9.65B | 9.08% |
Mar 31, 2022 | 106.34B | 17.69B | 19.96% |
Mar 31, 2021 | 88.65B | 5.21B | 6.24% |
Mar 31, 2020 | 83.44B | 9.87B | 13.42% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 211.46B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Fortis Healthcare | 77.83B |
Alkem Laboratories News
- 2 hours ago - Stocks to watch on May 30: Bajaj Auto, Ola Electric, Samvardhana Motherson, Suzlon, Alkem Labs in focus after key brokerage calls - Business Upturn
- 3 hours ago - Nomura maintains ‘Buy’ on Alkem Labs; expects Semaglutide launch to drive future growth - Business Upturn
- 3 hours ago - Jefferies maintains ‘Underperform’ on Alkem Labs and cuts target price to Rs 4,460 on margin concerns - Business Upturn
- 1 day ago - Stocks in focus on May 29: Bajaj Auto, Suzlon Energy, Alkem Labs, SJVN among 40 firms to report Q4 results - Business Upturn
- 2 months ago - Alkem Laboratories to acquire 100% stake in Bombay Ortho Industries - Business Upturn
- 2 months ago - Alkem Laboratories receives positive outcome from US FDA inspection at Taloja Bioequivalence Center - Business Upturn
- 2 months ago - Alkem Laboratories launches affordable generic empagliflozin in India - Business Upturn
- 3 months ago - Nomura upgrades Alkem Labs to Buy and believes that concerns around growth are in price - Business Upturn